Thyroid Carcinoma
R. Michael Tuttle(Memorial Sloan Kettering Cancer Center), Lori J. Wirth(Massachusetts General Hospital), Raza A. Dilawari, Cord Sturgeon(Northwestern University), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Steven G. Waguespack(The University of Texas MD Anderson Cancer Center), Douglas W. Ball(Johns Hopkins University), John A. Ridge(Fox Chase Cancer Center), Peter Kopp(Northwestern University), Gerard M. Doherty(Mass General Brigham), John A. Olson, Quan‐Yang Duh(University of California, San Francisco), Robert I. Haddad(Georgetown University), Judith C. McCaffrey, Steven I. Sherman(The University of Texas MD Anderson Cancer Center), William M. Lydiatt(Creighton University), Thom R. Loree(Memorial Sloan Kettering Cancer Center), Richard T. Kloos(Veracyte (United States)), David R. Byrd(University of Washington), William B. Farrar, Hormoz Ehya(Fox Chase Cancer Center), Fouad Kandeel(City of Hope), Lee Parks, Dominick Lamonica(Dana-Farber Brigham Cancer Center)
Cited by 205
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k